BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 14673528)

  • 1. CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia.
    Wasmuth HE; Werth A; Mueller T; Berg T; Dietrich CG; Geier A; Schirin-Sokhan R; Gartung C; Lorenzen J; Matern S; Lammert F
    J Mol Med (Berl); 2004 Jan; 82(1):64-9. PubMed ID: 14673528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of the CCR5-Delta32 mutant allele is not increased in Belgian hepatitis C virus-infected patients.
    Thoelen I; Verbeeck J; Wollants E; Maes P; Robaeys G; Matheï C; Buntinx F; Nevens F; Van Ranst M
    Viral Immunol; 2005; 18(1):232-5. PubMed ID: 15802968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.
    Woitas RP; Ahlenstiel G; Iwan A; Rockstroh JK; Brackmann HH; Kupfer B; Matz B; Offergeld R; Sauerbruch T; Spengler U
    Gastroenterology; 2002 Jun; 122(7):1721-8. PubMed ID: 12055576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.
    Ahlenstiel G; Woitas RP; Iwan A; Nattermann J; Feldmann G; Rockstroh JK; Oldenburg J; Kupfer B; Sauerbruch T; Spengler U
    Immunol Invest; 2009; 38(1):1-13. PubMed ID: 19172482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.
    Ahlenstiel G; Woitas RP; Iwan A; Nattermann J; Feldmann G; Rockstroh JK; Oldenburg J; Kupfer B; Sauerbruch T; Spengler U
    Immunol Invest; 2009; 38(3-4):284-96. PubMed ID: 19811439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic expressions of CCR5-delta32/delta32 homozygosity.
    Nguyêñ GT; Carrington M; Beeler JA; Dean M; Aledort LM; Blatt PM; Cohen AR; DiMichele D; Eyster ME; Kessler CM; Konkle B; Leissinger C; Luban N; O'Brien SJ; Goedert JJ; O'Brien TR
    J Acquir Immune Defic Syndr; 1999 Sep; 22(1):75-82. PubMed ID: 10534150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CC-chemokine receptor 5 (CCR5) in hepatitis C--at the crossroads of the antiviral immune response?
    Ahlenstiel G; Woitas RP; Rockstroh J; Spengler U
    J Antimicrob Chemother; 2004 Jun; 53(6):895-8. PubMed ID: 15128728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the CCR5 Delta32 polymorphism in abdominal aortic aneurysms.
    Sandford B; Bown M; London N; Sayers R
    Int J Immunogenet; 2009 Aug; 36(4):199-205. PubMed ID: 19476483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of CCR5-Δ32 against HIV infection by the heterosexual mode of transmission in a Polish population.
    Zwolińska K; Knysz B; Rybka K; Pazgan-Simon M; Gąsiorowski J; Sobczyński M; Gładysz A; Piasecki E
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):54-60. PubMed ID: 22957692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CC chemokine receptor 5 Δ32 polymorphism: association analysis and allele distribution among cutaneous leishmaniasis patients from Pakistan.
    Sophie M; Hameed A; Muneer A; Samdani AJ; Saleem S; Azhar A
    J Cutan Pathol; 2016 Jul; 43(7):564-70. PubMed ID: 26970327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR5 promoter polymorphism influences the interferon response of patients with chronic hepatitis C in Japan.
    Konishi I; Horiike N; Hiasa Y; Michitaka K; Onji M
    Intervirology; 2004; 47(2):114-20. PubMed ID: 15192276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Do polymorphisms of the SDF1 and CCR2b genes modify the course of hepatitis C or HIV/HCV co-infection?].
    Woitas RP; Ahlenstiel G; Iwan A; Rockstroh JK; Brackmann HH; Kupfer B; Matz B; Offergeld R; Sauerbruch T; Spengler U
    Dtsch Med Wochenschr; 2002 Sep; 127(36):1807-12. PubMed ID: 12215924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
    Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
    Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of higher frequency of the chemokine receptor 5-delta32/delta32 genotype in hepatitis C.
    Tommasi AM; Fabris P; Carderi I; Baragiotta A; Baldo V; Venturi C; Giordani MT; Tositti G; Floreani A
    J Clin Gastroenterol; 2006; 40(5):440-3. PubMed ID: 16721228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CC chemokine receptor 5 polymorphism in rheumatoid arthritis.
    Garred P; Madsen HO; Petersen J; Marquart H; Hansen TM; Freiesleben Sørensen S; Volck B; Svejgaard A; Andersen V
    J Rheumatol; 1998 Aug; 25(8):1462-5. PubMed ID: 9712084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source.
    Goulding C; McManus R; Murphy A; MacDonald G; Barrett S; Crowe J; Hegarty J; McKiernan S; Kelleher D
    Gut; 2005 Aug; 54(8):1157-61. PubMed ID: 15863470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease.
    Sharda S; Gilmour A; Harris V; Singh VP; Sinha N; Tewari S; Ramesh V; Agrawal S; Mastana S
    Int J Cardiol; 2008 Feb; 124(2):254-8. PubMed ID: 17383752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of CCR5-delta32 mutation in asthmatic and non-asthmatic subjects from department of medicine, JUCM, Cracow.
    Gomulska M; Rusin G; Gwiazdak P
    Folia Med Cracov; 2014; 54(4):5-13. PubMed ID: 25891238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the CCR5-Delta32 mutation on antiviral treatment in chronic hepatitis C.
    Ahlenstiel G; Berg T; Woitas RP; Grünhage F; Iwan A; Hess L; Brackmann HH; Kupfer B; Schernick A; Sauerbruch T; Spengler U
    J Hepatol; 2003 Aug; 39(2):245-52. PubMed ID: 12873822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the Chemokine Receptor 5 (CCR5)-Delta32 Mutation on Hepatitis C Virus-Specific Immune Responses and Liver Tissue Pathology in HCV Infected Patients.
    Yilmaz A; Alagozlu H; Ozdemir O; Arici S
    Hepat Mon; 2014 Jul; 14(7):e11283. PubMed ID: 25067937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.